LTF makes first investment
Article Date: Mar 30 2006
DeltaDOT, a developer of tools used in pharmaceutical and biotech research, has become the first firm to receive funding – to the tune of £600,000 – from the London Technology Fund.
A recent spin-out from Imperial College, deltaDOT has secured a total of £6 million, with the likes of Fleming Private Equity, Imperial College and Sitka VCT also investing. The company will use the cash to help commercialise its products, which are used by high-tech health firms to enhance the productivity of their research.
‘The growth of our business is accelerating as we transition from a research and product development company into a fully fledged commercial organisation,’ explains chief executive Anthony Baxter.
